Tuesday, February 25, 2020
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), Morgan Stanley (MS) and Sinopec (SNP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Johnson & Johnson’s shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+7.2% vs. +5.3%). The Zacks analyst believes that J&J is witnessing significant generic/biosimilar headwinds in the Pharma unit.
However, the unit is performing above-market levels, supported by contribution from new drugs like Tremfya and successful label expansion of cancer drugs like Imbruvica and Darzalex and immunology drug, Stelara. J&J is also making rapid progress with its pipeline and line extensions.
It gained FDA approval for two new drugs in 2019, Balversa and Spravato. Several pivotal data readouts and regulatory milestones are expected in 2020. Headwinds like biosimilar/generic competition and pricing pressure remain. J&J faces numerous lawsuits, which allege personal injuries to patients caused by the use of its products. These lawsuits have resulted in uncertainty.
(You can read the full research report on Johnson & Johnson here >>>)
Shares of Morgan Stanley have gained +23.7% in the past six months against the Zacks Investment Banking industry’s rise of +16.8%. The Zacks analyst believes that the company’s planned acquisition of E*Trade Financial for $13 billion will further support Wealth Management business.
Improving economy and focus on corporate lending operation are expected to continue supporting profitability. The company has an impressive earnings surprise history, having outpaced the Zacks Consensus Estimate in each of the trailing four quarters.
Although dependence on capital markets to generate trading and investment banking revenues, lower rates and continuously rising operating expenses are major near-term concerns, initiatives to further strengthen investment management operation are likely to support top-line growth. Also, enhanced capital deployment activities reflect a strong balance sheet position and will enhance shareholder value.
(You can read the full research report on Morgan Stanley here >>>)
Sinopec’s shares have lost 9.2% over the past three months against the Zacks Integrated Oil industry’s fall of 7.3%. The Zacks analyst believes that Sinopec’s natural gas business has immense potential for growth over the coming years as China intends to move from coal to natural gas.
Sinopec is among the largest integrated energy players in China, with significant presence in upstream and downstream businesses. Further, the company has made major progress in identifying economically-viable oil & gas reserves. A huge scale of prospective new reserves was discovered in a number of prolific oil & gas resources like Sichuan Basin & Jiyang Depression.
However, the disruption in China’s economy owing to the outbreak of coronavirus will continue to hurt the firm’s refining business. With declining demand for chemical products, the firm’s chemicals operations are expected to take a hit.
(You can read the full research report on Sinopec here >>>)
Other noteworthy reports we are featuring today include Blackstone Group (BX), American Electric Power (AEP) and Kinder Morgan (KMI).
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
J&J's (JNJ) Pharma Unit Shines Amid Generic/Litigation Woes
Acquisition, Corporate Lending Focus Aid Morgan Stanley (MS)
Sinopec (SNP) Banks on Gas-Rich Sichuan, Refining Hurts
Solid Fund Raising Aid Blackstone (BX) Amid Higher Costs
Per the Zacks analyst, Blackstone is poised to capitalize from its fund-raising ability, higher assets balance, acquisitions and global reach.
Renewable Expansion Aids American Electric (AEP), Costs Woe
Per the Zacks analyst, expanding renewable generation portfolio should boost American Electric's growth.
Kinder Morgan (KMI) to Grow on PHP Gas Pipeline Project
The Zacks analyst expects the PHP Pipeline project to fetch Kinder Morgan stable and additional fees-based revenues.
Rising Top-line Aids, High Debt Hurts HCA Healthcare (HCA)
Per the Zacks analyst, its growing top-line driven by increasing admissions has led to significant growth of the company.
Investments Aid Sempra Energy (SRE), Negative Rating Hurt
Per the Zacks analyst, systematic investments in infrastructure development projects bolster Sempra Energy. Its credit rating has been reduced in recent past that may affect its credibility.
Paychex (PAYX) Benefits From Oasis Buyout, Expenses High
Oasis Outsourcing adds to Paychex's top line. However, the Zacks analyst is worried about rising expenses due to PEO insurance costs, buyouts, investment in sales, marketing and product development.
Investments Aids Consolidated Edison (ED), Regulations Hurt
Per the Zacks Analyst, company's systematic capital investment plan for infrastructure development bolsters growth prospects. However, stringent utility regulations could be detrimental to growth.
Project Pipeline, Strong Product Demand Aids SunPower (SPWR)
Per the Zacks Analyst, SunPower is storage pipeline expansion and strategies to consolidate its position will drive earnings. It also witnesses strong demand for its varied product offering.
eBay (EBAY) Rides on Solid Momentum Across Managed Payments
Per the Zacks analyst, eBay is benefiting from strengthening managed payments offerings which deliver better shopping experience. This in turn is aiding the company's customer momentum.
Investment Income, Solid Balance Sheet Aids Amerisafe (AMSF)
Per the Zacks analyst, consistent increase in investment income over the years has contributed to the company's topline. Its solid balance sheet enables investment in business.
Plant Maintenance Downtime to Weigh on HollyFrontier (HFC)
The Zacks analyst is concerned by HollyFrontier's cost escalation associated with maintenance downtime and unplanned refinery shutdowns.
Increasing Expenses & Stiff Competition Hurt Shopify (SHOP)
Per the Zacks analyst, Shopify's increasing spend on fulfillment network, infrastructure and platform, amid stiff competition in the e-commerce market is likely to weigh on profitability.
Scientific Games (SGMS) Hurt By Competition, High Debt Level
Per the Zacks analyst, Scientific Games is negatively impacted by intensifying competition and a highly leveraged balance sheet.
China Petroleum & Chemical Corporation (SNP) : Free Stock Analysis Report
Morgan Stanley (MS) : Free Stock Analysis Report
Kinder Morgan, Inc. (KMI) : Free Stock Analysis Report
Johnson & Johnson (JNJ) : Free Stock Analysis Report
Blackstone Group Inc/The (BX) : Free Stock Analysis Report
American Electric Power Company, Inc. (AEP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research